findmyKOL
Clinical trialNCT03583086CompletedPhase 1/PHASE2Interventional

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

SponsorVanderbilt-Ingram Cancer CenterEnrollment88Non-small Cell Lung CancerRefractory Thoracic TumorsSmall-Cell Lung CancerThymic Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford Cancer Institute

    Palo Alto, California, United States

  • Winship Cancer Institute, Emory University

    Atlanta, Georgia, United States

  • University of Chicago Medical Center

    Chicago, Illinois, United States

  • Providence Cancer Institute Franz Clinic

    Portland, Oregon, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, United States

  • Baptist Clinical Research Institute

    Memphis, Tennessee, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Jul 2018
Primary completion
21 Feb 2024
Completion
27 Apr 2024
Last update posted
8 Oct 2024
Registered enrollment
88
Registry id
NCT03583086

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.